Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Summary
The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The main questions it aims to answer are: * Does the time between repeat injections differ from the 6-month standard when it is based on patient symptoms alone? * Does symptom control or patient satisfaction change when patients control their own follow up times? Participants will undergo standard botulinum toxin injection into the bladder for OAB treatment and will then be randomly assigned to follow up either at a standard 6-month interval or whenever they feel their symptoms return.
Official title: Optimal Injection Interval for Intra-Detrusor Botulinum Toxin: A Randomized Controlled Trial Utilizing a Patient-Centered Approach
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-07
Completion Date
2025-10
Last Updated
2024-07-17
Healthy Volunteers
No
Interventions
Patient-directed follow up
Patients will be instructed to follow up for repeat injection based on bladder symptomatology at their own self-determined time interval.
Locations (1)
Louisiana State University Health Science Center
New Orleans, Louisiana, United States